Boletín Nanomedicina Febrero 2011 by IALE Tecnología

Febrero 2011

Boletín Nanomedicina

generado por VIGIALE, IALE Tecnología.

HIDDEN TEXT TO MARK THE BEGINNING OF THE TABLE OF CONTENTS

INDICE NOTICIAS 1. Gene fuelled transporter causes breast cancer cells to self-destruct

2. Nanoparticles that mimic viruses can stimulate long lasting immunity

3. Fingerprints of a gold cluster revealed

4. Virus-Mimicking nanoparticles can stimulate long-lasting immunity

5. Clues to mystery of preterm delivery

6. Tuning the collective properties of artificial nanoparticle supercrystals

7. NanoBioConnect: A new tool to accelerate commercialization of nanobiotechnology

8. Prรณtesis articulares mรกs seguras

9. Engineered cells could usher in programmable cell therapies

10. Modified RNA creates stable therapeutic nanoparticles

11. Enabling nanoparticles to penetrate deeply in tumors

12. MIT engineers design new nanoparticle that could lead to vaccines

13. Simpler way of making proteins could lead to new nanomedicine agents

14. New technology in human trials to spot cardiac disease

15. Desarrollan un sistema de transporte de fรกrmacos antitumorales

16. Magnetic nanoparticles could track transplanted neural stem cells following spinal injury

17. Tiny 'microworms' could be implanted under the skin for continuous medical monitoring

18. Fresh technology for new cell creation

19. Unos nanotransportadores consiguen pasar

20. Next-Generation sensor technology to be developed by Optiqua-NTU Partnership

21. Tracking neural stem cells

22. Circulating tumor cell detection may be enhanced by nanoparticles

23. Drug encapsulation and gene therapies use new data obtained on liposomes

24. Precise new sensor employs hydrogels

PATENTES 25. Patentes publicadas este mes

26. Origen de los principales actores del mes

27. Principales titulares de las patentes del mes

28. Principales temas tratados en las patentes del mes

29. Principales inventores que patentaron este mes

30. US20110033522A1: Reagents for inducing an immune response

31. US20110038939A1: Therapeutic stable nanoparticles

32. US20110033550A1: Nanoparticle carriers for drug administration

33. US20110044893A1: Vascular targets for detecting, imaging and treating ..

34. US20110027174A1: Nanotubes for cancer therapy and diagnostics

INDICE 35. WO2011019211A2: Silk nanofiber nerve conduit and method for producing thereof

36. WO2011017456A2: Localized delivery of nanoparticles for therapeutic and diagnostic applications

37. US20110045031A1: Use of buckysome or carbon nanotube for drug delivery

38. US20110045055A1: Medical devices containing therapeutic agents

39. DK0912734T3: Chimeric heteromultimer adhesins

40. WO2011017313A1: Method of administering non-viral nucleic acid vectors to the eye

41. WO2011017442A2: Anti-RSV immunogens and methods of immunization

42. WO2011017690A2: Intracellular delivery of contrast agents with functionalized nanoparticles

43. US20110038905A1: Skin anti-aging agent for external use

44. US20110034916A1: Nanoparticle-mediated microwave treatment methods

45. WO2011012867A1: A delivery system comprising a silicon-containing material

46. US20110033419A1: Methods and compositions for treating cancer

47. WO2011012721A1: Carrier linked pramipexole prodrugs

48. WO2011014562A1: Methods and devices for targeted injection of microspheres

49. WO2011019954A2: Intracochlear drug delivery to the central nervous system

50. US20110038900A1: Nanoparticles for use in pharmaceutical compositions

EVENTOS, CURSOS Y SEMINARIOS 51. Concertation des nanorevetements (stakeholder dialogue on nanocoatings)

52. INRS Occupational Health Research Conference 2011

53. IV Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica

54. Nanotubes and Nanocomposites 2011

55. ImagineNano

56. COIN Hosts Nanomedicine Commercialization Workshop

57. NanoManufacturing Conference & Exhibits

58. 2nd NanoDiaRA Seminar

59. Conference Innovation in Healthcare: from Research to Market

60. 5th Concertation and Consultation Workshop on Micro-Nano-Bio convergence Systems

61. Latin American Biomedical Nanotechnology Showcase

62. Seminar on Micro- and Nanotechnology Based Tools for Early Detection of Diseases

63. MicroMaterials Nanomechanical Testing Technical Seminar

64. Nanotechnologies et risques: responsabilités et assurances?

ARTÍCULOSCIENTÍFICOS 65. Principales investigadores que publicaron este mes

INDICE 66. Principales entidades con publicaciones este mes

67. Principales temas tratados en los artículos científicos del mes

68. "Off-On" Electrochemical Hairpin-DNA-Based Genosensor

69. Biostability of y-Fe2O3 nano particles

70. Size and surface charge of gold nanoparticles..

71. Problems and challenges in the development and validation of human cell-based assays..

72. Solid lipid nanoparticles reduce systemic toxicity of docetaxel

73. Cellular response of RAW 264.7 to spray-coated multi-walled carbon nanotube films

74. Analysis of Amyloid-b; Peptides in cerebrospinal fluid samples by capillary electrophoresis

75. Human skin penetration of gold nanoparticles through intact and damaged skin

76. Hazard identification of particulate matter on vasomotor dysfunction and atherosclerosis

77. Contribution of nano-copper particles to in vivo liver dysfunction and cellular damage

78. Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions

79. An effective strategy for the synthesis of biocompatible gold nanoparticles

80. Spherical bioactive glass particles and their interaction with human mesenchymal stem cells

81. Human skin penetration of gold nanoparticles through intact and damaged skin

REPORTES, LIBROS, OTRAS PUBLICACIONES 82. Nanotoxicology: An Interdisciplinary Challenge

83. Nanotechnology in Medicine - Pharma-Reports

84. La nanotecnología española se coloca a la vanguardia internacional del sector

85. Drug Regulation in the Modern Era

86. Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches

87. Biochips - Products, Applications, Technologies and End-use Markets Growth Analysis

88. Nanomedicines in Argentina 2011

Nanomedicina NOTICIAS Gene fuelled transporter causes breast cancer cells to self-destruct Publicada en Nanomedicine Research - News, 02/28/2011.

Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published February 28 in the International Journal of Pharmaceutics. ver mรกs...

Nanoparticles that mimic viruses can stimulate long lasting immunity Publicada el 02/28/2011.

Vaccine scientists say their "Holy Grail" is to stimulate immunity that lasts for a lifetime. Live viral vaccines such as the smallpox or yellow fever vaccines provide immune protection that lasts several decades, but despite their success, scientists have remained in the dark as to how they induce such long lasting immunity.

ver mรกs...

Fingerprints of a gold cluster revealed Publicada el 02/25/2011.

Nanometre-scale gold particles are currently intensively investigated for possible applications in catalysis, sensing, photonics, biolabelling, drug carriers and molecular electronics. The particles are prepared in a solution from gold salts and their reactive gold cores can be stabilised with various organic ligands. ver mรกs...

Virus-Mimicking nanoparticles can stimulate long-lasting immunity Publicada en Nanomedicine Research - News, 02/24/2011.

ver mรกs...

Febrero 2011

Pรกgina 2

Nanomedicina Clues to mystery of preterm delivery Publicada el 02/24/2011.

Scientists know that calcifying nanoparticles are involved in many degenerative conditions including arthritis and atherosclerosis. ver más...

Tuning the collective properties of artificial nanoparticle supercrystals Publicada el 02/24/2011.

Due to precise positioning of the NCs within a 3-D superlattice, such systems are frequently referred to as supercrystals (SCs) in analogy to crystals built of atoms. ver más...

NanoBioConnect: A new tool to accelerate commercialization of nanobiotechnology Publicada el 02/24/2011.

The Center of Innovation for Nanobiotechnology (COIN) today announced the launch of an information-rich, comprehensive nanobiotechnology information portal available to the public called NanoBioConnect. ver más...

Prótesis articulares más seguras Publicada el 02/24/2011.

Un grupo de investigadores del MIT está desarrollando recubrimientos para implantes médicos capaces de ser cargados con múltiples medicamentos, incluyendo antibióticos que se liberan a través del tiempo. ver más...

Engineered cells could usher in programmable cell therapies Publicada el 02/24/2011.

In work that could jumpstart the promising field of cell therapy, in which cells are transplanted into the body to treat a variety of diseases and tissue defects. ver más...

Febrero 2011

Página 3

Nanomedicina Modified RNA creates stable therapeutic nanoparticles Publicada el 02/24/2011.

But by replacing a chemical group in the macromolecule, Dr. Guo says he and fellow researchers have found a way to bypass RNase and create stable three-dimensional configurations of RNA, greatly expanding the possibilities for RNA in nanotechnology. ver mรกs...

Enabling nanoparticles to penetrate deeply in tumors Publicada el 02/24/2011.

Now, a large team of researchers from the Massachusetts Institute of Technology, have developed a solution to this problem: multilayered, or multistage, nanoparticles that partially dissolve once they accumulate around tumors, leaving behind a payload of nanoparticles a mere one-tenth the size of the original delivery vehicle.

ver mรกs...

MIT engineers design new nanoparticle that could lead to vaccines Publicada el 02/24/2011.

The new particles, consist of concentric fatty spheres that can carry synthetic versions of proteins normally produced by viruses. These synthetic particles elicit a strong immune response comparable to that produced by live virus vaccines but should be much safer. ver mรกs...

Simpler way of making proteins could lead to new nanomedicine agents Publicada el 02/23/2011.

Researchers have developed a simple method of making short protein chains with spiral structures that can also dissolve in water, two desirable traits not often found together. Such structures could have applications as building blocks for self-assembling nanostructures and as agents for drug and gene delivery.

ver mรกs...

Febrero 2011

Pรกgina 4

Nanomedicina New technology in human trials to spot cardiac disease Publicada el 02/23/2011.

Cardiac disease is the focus of one of six ongoing major clinical trials of Rice's programmable bio-nano-chips (PBNCs). ver más...

Desarrollan un sistema de transporte de fármacos antitumorales Publicada el 02/20/2011.

Científicos mexicanos trabajan en el desarrollo de un sistema de transporte de fármacos citotóxicos, que permitirá inyectar de manera simultánea agentes de quimio y radioterapia, dirigidos específicamente a tumores y células cancerosas, con lo que se reducirán los efectos tóxicos secundarios en tejidos y órganos sanos.

Magnetic nanoparticles could track transplanted neural stem cells following spinal injury Publicada el 02/18/2011.

Tracking magnetic nanoparticles attached to stem cells transplanted into spinal cords to heal injuries could be an effective way to monitor the healing process non-invasively say UK scientists. ver más...

Tiny 'microworms' could be implanted under the skin for continuous medical monitoring Publicada el 02/17/2011.

Researchers at MIT and Northeastern have come up with a new system for monitoring biomedical indicators -- such as levels of sodium or glucose in the blood -- that could someday lead to implantable devices that would allow, for example, people with diabetes to check their blood sugar just by glancing at an area of skin.

Fresh technology for new cell creation

Febrero 2011

Página 5

Nanomedicina Publicada el 02/16/2011.

Enter the MODPLEUV project, which brought together Austrian, Czech and Polish researchers to successfully develop a novel yet easy way to create nano-structured materials that would facilitate human cell development. MODPLEUV is supported by EUREKA, the European platform for research and development (R&D).

Unos nanotransportadores consiguen pasar Publicada en Technology Review, 02/16/2011.

Un nuevo sistema de nanotransporte es capaz de colar tratamientos contra el cáncer a través de las defensas de las células tumorales resistentes a los fármacos, ofreciendo esperanza a muchos pacientes de cáncer que se benefician poco de los tratamientos farmacológicos existentes. ver más...

Next-Generation sensor technology to be developed by OptiquaNTU Partnership Publicada el 02/16/2011.

To enhance its contaminant-detection capability, Optiqua Technologies Pte Ltd is collaborating with Nanyang Technological University (NTU) to tap on its expertise in biomolecular sciences and sensor technology.

Tracking neural stem cells Publicada el 02/14/2011.

Magnetic nanoparticles could be used to track neural stem cells after a transplant in order to monitor how the cells heal spinal injuries, say UCL scientsts. ver más...

Circulating tumor cell detection may be enhanced by nanoparticles Publicada el 02/14/2011.

Tiny gold particles can help doctors detect tumor cells circulating in the blood of patients with head and neck cancer, researchers at Emory and Georgia Tech have found. ver más...

Febrero 2011

Página 6

Nanomedicina Drug encapsulation and gene therapies use new data obtained on liposomes Publicada el 02/09/2011.

University of Granada scientists and the Spanish Higher Institute for Scientific Research (CSIC) have made significant progress in understanding lipid membranes, which are extensively employed in the development of cosmetic and drug products, and which have potential application in the field of nanotechnology.

ver mรกs...

Precise new sensor employs hydrogels Publicada el 02/09/2011.

Researchers are developing a new type of biological and chemical sensor that has few moving parts, is low-cost and yet highly sensitive, sturdy and long-lasting.

ver mรกs...

PATENTES Patentes publicadas este mes Publicada el 02/28/2011.

Fuente: Espacenet, USPTO

Febrero 2011

Pรกgina 7

Nanomedicina Origen de los principales actores del mes Publicada el 02/28/2011.

Fuente: Espacenet, USPTO

Principales titulares de las patentes del mes Publicada el 02/28/2011.

Fuente: Espacenet, UPSTO

Febrero 2011

Pรกgina 8

Nanomedicina Principales temas tratados en las patentes del mes Publicada el 02/28/2011.

Fuente: Espacenet, UPSTO

Principales inventores que patentaron este mes Publicada el 02/28/2011.

Fuente: Especenet, USPTO

Febrero 2011

Pรกgina 9

Nanomedicina US20110033522A1: Reagents for inducing an immune response Publicada el 02/24/2011.

Inventor: Reinherz Ellis L. Titular: Dana Farber Cancer Inst Inc (EE.UU.); Harvard College (EE.UU.); Massachusetts Inst Technology (EE.UU.) Resumen: The present disclosure relates to reagents and kits that are useful in a variety methods for inducing an immune response. ver más...

US20110038939A1: Therapeutic stable nanoparticles Publicada el 02/24/2011.

Inventor: Lvov Yuri. Titulares: Univ Northeastern; Louisiana Tech University Res Foundation a Division of Louisiana Tech University Foundation (EE.UU.) Resumen: Stable colloid nanoparticles comprising poorly soluble drugs are disclosed. ver más...

US20110033550A1: Nanoparticle carriers for drug administration Publicada el 02/24/2011.

Inventor: Kalombo Lonji. Titular: CSIR (Sudáfrica) Resumen: The invention provides a process for the production of nanoparticle carriers for drug delivery.

US20110044893A1: Vascular targets for detecting, imaging and treating .. Publicada el 02/24/2011.

Inventor y Titular: Schnitzer Jan E (EE.UU.) Resumen: Methods of delivering an agent in a tissue-specific manner, by targeting annexin A1, a derivative of annexin A1, or a binding partner of annexin A1, are described. ver más...

US20110027174A1: Nanotubes for cancer therapy and diagnostics

Febrero 2011

Página 10

Nanomedicina Publicada el 02/24/2011.

Inventor y Titular: Buzatu Dan A (EE.UU.). Resumen: The present invention provides a novel approach to cancer therapy and diagnostics that utilizes nanotubes and other similar nanostructures.

ver mรกs...

WO2011019211A2: Silk nanofiber nerve conduit and method for producing thereof Publicada el 02/24/2011.

Inventor: Park Young Hwan. Titular: Snu R&Db Foundation (Corea del Sur). Resumen: The present invention relates to a silk nanofiber nerve conduit characterized in that fibroin nanofibers, are stacked layer upon layer to form a porous conduit-shape; and a method for producing thereof.

ver mรกs...

WO2011017456A2: Localized delivery of nanoparticles for therapeutic and diagnostic applications Publicada el 02/24/2011.

Inventor: Mirkin Chad A. Titular: Univ Northwestern (EE.UU.) Resumen: The present invention is directed to compositions and methods of localized delivery of a functionalized nanoparticle.

ver mรกs...

US20110045031A1: Use of buckysome or carbon nanotube for drug delivery Publicada el 02/24/2011.

Inventor: Hirsch Andreas. Titular: Ensysce Biosciences Inc (EE.UU.) Resumen: Compositions and methods for administering a therapeutic agent to a mammal are disclosed. ver mรกs...

Febrero 2011

Pรกgina 11

Nanomedicina US20110045055A1: Medical devices containing therapeutic agents Publicada el 02/24/2011.

Inventor: Hingston John. Titular: Boston Scient Scimed Inc (EE.UU.) Resumen: According to one aspect of the invention, implantable or insertable medical devices are provided which can delay release of one or more therapeutic agents for a predetermined time after implantation in a subject.

ver mรกs...

DK0912734T3: Chimeric heteromultimer adhesins Publicada el 02/24/2011.

Inventor: Sliwkowski Mark. Titular: Genentech Inc (EE.UU.) Resumen: Chimeric heteromultimer adhesins that bind the ligand of natural heteromultimeric receptors and uses therefor are disclosed. ver mรกs...

WO2011017313A1: Method of administering non-viral nucleic acid vectors to the eye Publicada el 02/24/2011.

Inventor: Cooper Mark J. Titular: Copernicus Therapeutics Inc (EE.UU.) Resumen: Intravitreal administration of nucleic acid vectors leads to transfection and expression of the nucleic acid vectors in retinal pigment epithelium. ver mรกs...

WO2011017442A2: Anti-RSV immunogens and methods of immunization Publicada el 02/24/2011.

Inventor: Anderson Larry J. Titular: US Government (EE.UU.) Resumen: Immunogenic polypeptides corresponding to one or more RSV G glycoproteins, or analogues thereof, are provided as components of vaccines. ver mรกs...

Febrero 2011

Pรกgina 12

Nanomedicina WO2011017690A2: Intracellular delivery of contrast agents with functionalized nanoparticles Publicada el 02/24/2011.

Inventor: Mirkin Chad A. Titular: Univ Northwestern (EE.UU.) Resumen: The present invention is directed to compositions and methods for intracellular delivery of a contrast agent with a functionalized nanoparticle.

US20110038905A1: Skin anti-aging agent for external use Publicada el 02/24/2011.

Inventores: Aimi Makiko. Titular: Fujifilm Corp (Japón) Resumen: The present invention provides a skin anti-aging agent for external use, which comprises protein nanoparticles containing an active ingredient.

US20110034916A1: Nanoparticle-mediated microwave treatment methods Publicada el 02/24/2011.

Inventor y Titular: Te Alexis. Titulares(EE.UU.) Resumen: A method is provided for using magnetic nanoparticles to enhance microwave therapies for treating cells and tissues. ver más...

WO2011012867A1: A delivery system comprising a siliconcontaining material Publicada el 02/24/2011.

Inventor: Saffie-Siebert Roghieh. Titular: Sisaf Ltd (Reino Unido) Resumen: A composition comprising nanoparticles of a hydrolysable silicon-contain material for use as a delivery system for a bioactive ingredient and a method of promoting the controlled release of orthosilicic acid.

Febrero 2011

Página 13

Nanomedicina US20110033419A1: Methods and compositions for treating cancer Publicada el 02/24/2011.

Inventor: Aurellan Laure. Titular: Univ Maryland (EE.UU.) Resumen: The invention further relates to pharmaceutical compositions comprising HSV-2 virus, wherein the virus lacks protein kinase activity of ICP10.

ver mรกs...

WO2011012721A1: Carrier linked pramipexole prodrugs Publicada el 02/23/2011.

Inventor: Rau Harald. Titular: Ascendis Pharma AS (Dinamarca) Resumen: The present invention relates to a carrier linked pramipexole prodrug or a pharmaceutical acceptable salt thereof, wherein pramipexole is bound via a linker to a polymeric carrier. ver mรกs...

WO2011014562A1: Methods and devices for targeted injection of microspheres Publicada el 02/23/2011.

Inventor: Kleinstreuer Clement. Titular: Univ North Carolina State (EE.UU.) Resumen: A "Smart Micro-catheter" (SMC) system comprising a device for controlled particle release and drug delivery into a blood vessel, hepatic artery or any patho-physiological target is disclosed. ver mรกs...

WO2011019954A2: Intracochlear drug delivery to the central nervous system Publicada el 02/23/2011.

Inventor: Ivri Yehuda. Titular: Ivri Yehuda (EE.UU.) Resumen: The present invention is directed to method and system for delivery of brain-targeted drugs to the cerebrospinal fluid via the perilymphatic fluid of the inner ear. ver mรกs...

Febrero 2011

Pรกgina 14

Nanomedicina US20110038900A1: Nanoparticles for use in pharmaceutical compositions Publicada el 02/22/2011.

Inventor: Chakrapani Aravind. Titular: Novartis AG (Suiza) Resumen: In various aspects of the present invention, nanoparticle compositions are provided which comprise (a) nanoparticles comprising at least one biodegradable polymer and (b) at least one pharmaceutical associated with the nanoparticles. ver más...

EVENTOS, CURSOS Y SEMINARIOS Concertation des nanorevetements (stakeholder dialogue on nanocoatings) Publicada en NanoForum.org-Events, 02/28/2011.

Pour enrichir lexpertise par la concertation, progresser dans lécoute et la compréhension des autres points de vues (parties apprenantes) et approfondir les controverses. Fecha: 15 March 2011 Lugar: Paris, France ver más...

INRS Occupational Health Research Conference 2011 Publicada el 02/23/2011.

Occupational Health Research Conference 2011: Risks associated to Nanoparticles and Nanomaterials. Fecha: 05 - 07 April 2011 Lugar: Nancy, France ver más...

IV Conferencia Anual de las Plataformas Tecnológicas de Investigación Biomédica Publicada el 02/23/2011.

La cita anual de las tres Plataformas Tecnológicas de Investigación Biomédica bordará la cooperación farma-biotech, como una necesidad puesta de manifiesto en el modelo de investigación de nuevos medicamentos y tecnologías sanitarias. Fecha: 28 de febrero - 1 de marzo de 2011 Lugar: Palacio Municipal de Congresos de Madrid.

Febrero 2011

Página 15

Nanomedicina Nanotubes and Nanocomposites 2011 Publicada el 02/23/2011.

Will focus on research and development in all nano-particles, polymer processing and application, as well as market direction, growth and potential for commercialisation. Fecha: April 06 - 07, 2011 Lugar: Le Meridien Brussels, Brussels, Belgium ver más...

ImagineNano Publicada el 02/23/2011.

Extensive thematic conferences will be held in parallel and a huge industrial exhibition carried out with the latest nanotrends for the future. Fecha: Apr 11 - 14, 2011 Lugar: Bilbao, España ver más...

COIN Hosts Nanomedicine Commercialization Workshop Publicada el 02/23/2011.

The topic of the workshop will be Actionable Strategies for Company Building & Moving to Market. Fecha: Mar 29, 2011 Lugar: Charlotte North Carolina, EE.UU. ver más...

NanoManufacturing Conference & Exhibits Publicada el 02/23/2011.

This conference will highlight the current, near-term, and future applications of nanotechnology and how they are transforming the way we manufacture products. Fecha: Apr 05 - 06, 2011 Lugar: Oakbrook Terrace (Chicago) IL, EE.UU. ver más...

2nd NanoDiaRA Seminar Publicada el 02/23/2011.

NanoDiaRA, a consortium of 15 partners, is looking forward to welcoming interested people from research and development, industry and society and to show you new approaches of in-vitro and in-vivo technologies. Fecha: 18 March 2011 Lugar: Neuchâtel, Switzerland

Febrero 2011

Página 16

Nanomedicina

Conference Innovation in Healthcare: from Research to Market Publicada el 02/23/2011.

The objective of the 2011 conference is to produce an analysis of the strengths, weaknesses, opportunities and threats (SWOT) for innovation in healthcare and make specific recommendations that will be addressed to policymakers and stakeholders. Fecha: 30-31 March 2011 Lugar: Brussels ver más...

5th Concertation and Consultation Workshop on Micro-Nano-Bio convergence Systems Publicada el 02/23/2011.

Co-organized by the European Commission and IKERLAN-IK4 a private not-profit Technological Research Centre in the north of Spain. Fecha: April 05 - 06, 2011 Lugar: Mondragón, Spain. ver más...

Latin American Biomedical Nanotechnology Showcase Publicada el 02/23/2011.

Workshop participants must be registered users of ICPC-Nanonet. Registration is free. Fecha: 23 March 2011 Lugar: in internet, Great Britain ver más...

Seminar on Micro- and Nanotechnology Based Tools for Early Detection of Diseases Publicada en European Technology Platform of Nanomedicine - Events, 02/18/2011.

Febrero 2011

Página 17

Nanomedicina MicroMaterials Nanomechanical Testing Technical Seminar Publicada en AzoNanotechnology-Eventos, 02/18/2011.

Each Micro Materials Nanomechanical Testing Technical Seminar will provide an introduction to the theory, current research and live demonstrations. Fecha: March 01, 2011 Lugar: Oxford University Begbroke Science Park, EE.UU. ver más...

Nanotechnologies et risques: responsabilités et assurances? Publicada en NanoForum.org-Events, 02/18/2011.

Organized by: Vivagora Fecha: 22 March 2011 Lugar: Paris, France ver más...

ARTÍCULOS-CIENTÍFICOS Principales investigadores que publicaron este mes Publicada el 02/28/2011.

Fuente: Scopus

Febrero 2011

Página 18

Nanomedicina Principales entidades con publicaciones este mes Publicada el 02/28/2011.

Fuente: Scopus

Principales temas tratados en los artículos científicos del mes Publicada el 02/28/2011.

Fuente: Scopus

Febrero 2011

Página 19

Nanomedicina "Off-On" Electrochemical Hairpin-DNA-Based Genosensor Publicada el 02/23/2011.

Autor: Farjami E. Resumen: A simple and robust "off-on" signaling genosensor platform with improved selectivity for single-nucleotide polymorphism (SNP) detection based on the electronic DNA hairpin molecular beacons has been developed.

ver mรกs...

Biostability of y-Fe2O3 nano particles Publicada el 02/23/2011.

Autor: Kwon-Jai Leea. Resumen: This study examined the cytotoxic effects of the y-Fe2O3 magnetic nanoparticles (GMNs) on a range of tumor cell lines. ver mรกs...

Size and surface charge of gold nanoparticles.. Publicada el 02/23/2011.

Autor: Schleh C. Resumen: In this study, radiolabelled gold nanoparticles in different sizes (1.4200 nm) with negative surface charge and 2.8 nm nanoparticles with opposite surface charges were administered by intra-oesophageal instillation into healthy adult female rats. ver mรกs...

Problems and challenges in the development and validation of human cell-based assays.. Publicada el 02/23/2011.

Autor: Oostingh GJ. Resumen: In a collaborative work between European laboratories, existing immunological and toxicological in vitro assays were tested and compared for their suitability to test effects of nanoparticles on immune responses. ver mรกs...

Solid lipid nanoparticles reduce systemic toxicity of docetaxel

Febrero 2011

Pรกgina 20

Nanomedicina Publicada el 02/23/2011.

Autor: Gao Y. Resumen: In this study, the new docetaxel-loaded solid lipid nanoparticles (DSNs) were prepared, and systemic toxicity of DSNs in different animals was comprehensively investigated for allergenicity and vascular irritation in mice and beagle dogs. ver mรกs...

Cellular response of RAW 264.7 to spray-coated multi-walled carbon nanotube films Publicada el 02/23/2011.

Autor: Chen H. Resumen: In this paper, the authors studied the potential health effect of carbon nanotube (CNT) films fabricated with three commercial surfactants (sodium cholate, sodium dodecyl sulfate, and triton X-100).

ver mรกs...

Analysis of Amyloid-b; Peptides in cerebrospinal fluid samples by capillary electrophoresis Publicada el 02/23/2011.

Autor: Verpillot R. Resumen: We report a CE-LIF method for the separation and detection of five synthetic amyloidbeta; peptides corresponding to an important family of CSF-biomarkers in the context of Alzheimer disease (AD).

ver mรกs...

Human skin penetration of gold nanoparticles through intact and damaged skin Publicada el 02/23/2011.

Autor: Larese Filon F. Resumen: In this study, experiments were performed with gold nanoparticles (AuNPs) using the Franz diffusion cell method with intact and damaged human skin. ver mรกs...

Hazard identification of particulate matter on vasomotor dysfunction and atherosclerosis

Febrero 2011

Pรกgina 21

Nanomedicina Publicada el 02/23/2011.

Autor: Pøller. Resumen: The development and use of nanoparticles have alerted toxicologists and regulators to issues of safety testing. ver más...

Contribution of nano-copper particles to in vivo liver dysfunction and cellular damage Publicada el 02/23/2011.

Autor: Manna P. Resumen: In this study, the oxidative stress responsive cell signaling in nano-copper-induced hepatic dysfunction and cell death was investigated. ver más...

Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions Publicada el 02/23/2011.

Autor: Cho WS. Resumen: In this study, nickel, zinc, and copper oxide nanoparticles (NiONP, ZnONP, and CuONP) and their aqueous extracts (AEs) were applied to A549 lung epithelial cells to determine the cytotoxicity, IL-8 production, and activation of transcription factors. ver más...

An effective strategy for the synthesis of biocompatible gold nanoparticles Publicada el 02/23/2011.

Autor: Chanda N. Resumen: In this study, cinnamon-coated gold nanoparticles (Cin-AuNPs) were synthesized by a "green" procedure, and the detailed characterization was performed by physico-chemical analysis.

Spherical bioactive glass particles and their interaction with human mesenchymal stem cells Publicada el 02/23/2011.

Autor: Labbaf S. Resumen: In this study, sub-micron particles of bioactive glass (SMBGs) were synthesised and characterised and the effect of exposure of SMBGs to human mesenchymal stem cells (hMSCs) on cell viability, metabolic activity and proliferation were determined using the LIVE/DEAD, MTT, total DNA and LDH assays.

Febrero 2011

Página 22

Nanomedicina ver más...

Human skin penetration of gold nanoparticles through intact and damaged skin Publicada en Virtual Journal of Nanotechnology Environment, Health and Safety, 02/16/2011.

Autor: Larese Filon F. Resumen: In this study, experiments were performed with gold nanoparticles (AuNPs) using the Franz diffusion cell method with intact and damaged human skin. ver más...

REPORTES, LIBROS, OTRAS Nanotoxicology: An Interdisciplinary Challenge Publicada el 02/23/2011.

This Review seeks to cast light on the phenomena that may occur as nanoobjects interact with cells, tissues, and organisms and points out the aspect of reliability of studies with specific examples from the literature including a discussion of inadequate methods together with recommendations how to avoid this in the future.

Nanotechnology in Medicine - Pharma-Reports Publicada el 02/23/2011.

Nanotechnology is already being used in products in its passive form, such as cosmetics and sunscreens, and it is expected that in the coming decades, new phases of products, such as better batteries and improved electronics equipment, will be developed and have far©\reaching implications. ver más...

La nanotecnología española se coloca a la vanguardia internacional del sector Publicada el 02/23/2011.

El objetivo del Plan Nacional de I+D+i del Gobierno 2008-2011, es mejorar la competitividad de la industria española mediante la generación de cambios sustanciales en un amplio rango de sectores a través de la implementación y el desarrollo de nuevas aplicaciones y convergencias de diferentes tecnologías y disciplinas, entre las que destacan la nanociencia y nanotecnología (N&N).

Febrero 2011

Página 23

Nanomedicina ver más...

Drug Regulation in the Modern Era Publicada el 02/23/2011.

Remarks of Margaret A. Hamburg, M.D. Commissioner of Food and Drugs ver más...

Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches Publicada el 02/23/2011.

The report provides a comprehensive insight into the role of Nanotechnology in Drug Delivery. The report also provides a detailed analysis of market characterization of nanotechnology in drug delivery market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. ver más...

Biochips - Products, Applications, Technologies and End-use Markets Growth Analysis Publicada el 02/23/2011.

Global Market Watch: Global biochips market is forecasted to reach US$9.1 billion by 2015 with a CAGR of 20.9% during 2009-2015; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union.

Nanomedicines in Argentina 2011 Publicada el 02/15/2011.

Alejandro Sosnik and Eder Romero present their personal view of the current Nanomedicine landscape in Argentina.

Febrero 2011

Página 24